Form 4 for MDT Medtronic
Accepted 2026-08-04 19:59:46 ET · period of report 2026-07-31 · accession 0002137804-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-04 19:59 | 2026-07-31 | MDT | Thompson Kweli | EVP, Pres, Neuroscience | F - Tax | $85.39 | -1,739 | 28.5K | -6% | -$148.5K |
| D | 2026-08-04 19:59 | 2026-08-03 | MDT | Thompson Kweli | EVP, Pres, Neuroscience | A - Grant | $0.00 | +6,923 | 35.4K | +24% | $0 |
| DM | 2026-08-04 19:59 | 2026-08-03 | MDT | Thompson Kweli | EVP, Pres, Neuroscience | A - Grant | $0.00 | +66.5K | 49.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-07-31 | F | D | 1,739 | $85.39 | 28,467 | D | — | — | (F1) Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. (F2) Includes 188 shares acquired through dividend reinvestment since the last report filed by the reporting person. |
| 2 | Common | Ordinary Shares | 2026-08-03 | A | A | 6,923 | $0.00 | 35,390 | D | — | — | (F3) Represents restricted stock units that vest 100% on the third anniversary of the date of grant. |
| 3 | Derivative | Performance Share Units | 2026-08-03 | A | A | 17,306 | $0.00 | 17,306 | D | — · — to — | 17,306 Ordinary Shares | (F4) Each performance share unit represents a contingent right to receive one share of Medtronic common stock. (F5) Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029. (F5) Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029. (F6) The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 17,306 shares will be issued. If maximum performance metrics are achieved, 41,534 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-08-03 | A | A | 49,167 | $0.00 | 49,167 | D | $86.68 · — to 2036-08-03 | 49,167 Ordinary Shares | (F7) These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. |